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Force-bearing tissues such as blood vessels, lungs, and ligaments depend on the properties of elasticity and
flexibility. The 10 to 12 nm diameter fibrillin microfibrils play vital roles in maintaining the structural integrity of
these highly dynamic tissues and in regulating extracellular growth factors. In humans, defective microfibril
function results in several diseases affecting the skin, cardiovascular, skeletal, and ocular systems. Despite
the discovery of fibrillin-1 having occurred more than two decades ago, the structure and organization of
fibrillin monomers within the microfibrils are still controversial. Recent structural data have revealed strate-
gies by which fibrillin is able to maintain its architecture in dynamic tissues without compromising its ability
to interact with itself and other cell matrix components. This review summarizes our current knowledge of
microfibril structure, from individual fibrillin domains and the calcium-dependent tuning of pairwise interdo-
main interactions to microfibril dynamics, and how this relates to microfibril function in health and disease.Introduction
Connective tissue comprises loosely packed cells surrounded
by extensive extracellular matrix and has evolved to withstand
mechanical force. The properties of elasticity and extensibility
are vital in connective tissues such as blood vessels, lungs,
and ligaments. Among the major components of these force-
bearing tissues are the 10 to 12 nm diameter fibrillin-containing
microfibrils, which are found in both vertebrate and invertebrate
species (Faury, 2001). In vertebrate tissues, fibrillin microfibrils
are found at the periphery of elastic fibers, where they provide
a scaffold for the deposition of elastin during elastogenesis
(Jones et al., 1980; Kewley et al., 1978; Ross and Bornstein,
1969) (Figure 1A). They also occur in elastin-free bundles in
tissues such as the ciliary zonule, tendon, cornea, renal glomer-
ulus, and fetal membranes (Kumaratilake et al., 1989; Malak and
Bell, 1994; Sakai et al., 1986). In humans, defects in the fibrillin-1
and fibrillin-2 genes have been linked to diseases that affect the
cardiovascular, skeletal, and ocular systems, including Marfan
syndrome (Dietz et al., 1991) and congenital contractural arach-
nodactyly (Lee et al., 1991). The architecture of microfibrils has
remained remarkably conserved through evolution with struc-
tures resembling vertebrate microfibrils (Figure 1B) occurring in
the tissues of several invertebrate species, which lack elastin
(Birenheide and Motokawa, 1994; Davison et al., 1995; Reber-
Mu¨ller et al., 1995; Thurmond and Trotter, 1996). In invertebrate
species and in elastin-free tissues of vertebrates, it is the fibrillin-
containing microfibrils that confer the properties of elasticity and
extensibility to the extracellular matrix (Keene et al., 1991;
McConnell et al., 1997). The high degree of structural conserva-
tion seen throughout evolution highlights the importance of this
function in the connective tissues of metazoan species.
In addition to their functions as elastomeric components of
connective tissue, the role of fibrillin microfibrils in tissue homeo-
stasis through interactions with growth factors such as trans-
forming growth factor b (TGFb) and the bone morphogenetic
proteins (BMPs) has been highlighted in recent years (NeptuneStructuet al., 2003). Fibrillin interacts with several proteins (Figure 1C),
including the latent transforming growth factor-b-binding
proteins (LTBPs) 1, 2, and 4 (Hirani et al., 2007; Isogai et al.,
2003), microfibril-associated glycoprotein (MAGP)-1 and -2
(Hanssen et al., 2004; Jensen et al., 2001; Rock et al., 2004),
and fibulins (El-Hallous et al., 2007; Freeman et al., 2005; Rein-
hardt et al., 1996b). It also interacts with the prodomains of
several growth factors, including BMPs 2, 4, 7, and 10, and
growth and differentiation factor 5 (Sengle et al., 2008), and dys-
regulation of TGFb is seen in several diseases caused by defec-
tive fibrillin microfibril function (Le Goff et al., 2011; Loeys et al.,
2010; Ramirez and Rifkin, 2009).
Despite the identification in 1986 of fibrillin-1 as themain struc-
tural component of microfibrils (Sakai et al., 1986), the precise
organization of fibrillins within the microfibrils, their association
with cell matrix components, and the mechanisms of microfibril
elasticity are still a matter of debate. The difficulties in studying
these aspects of microfibril structure and interactions stem
from the rapid, covalent incorporation of newly secreted fibrillin
monomers into the matrix (Reinhardt et al., 2000), and the stabi-
lization of microfibril bundles by transglutaminase-derived
cross-links (Qian and Glanville, 1997). Recent structural studies,
however, have started to reveal some of the strategies by which
fibrillin is able to maintain its architecture in highly dynamic envi-
ronments without compromising its ability to interact with other
cell and matrix components.
Fibrillin Structure
The Fibrillins: Domain Organization
The fibrillins are a group of threeproteins, fibrillin-1, fibrillin-2, and
fibrillin-3, encoded by separate genes (Corson et al., 1993, 2004;
Nagase et al., 2001; Pereira et al., 1993; Zhang et al., 1994).
Analysis of cDNA sequences has shown that fibrillin domain
structure is dominated by epidermal-growth-factor (EGF)-like
domains of both the calcium-binding (cbEGF) and non-
calcium-binding types (EGF) (Figure 2). These are interspersedre 20, February 8, 2012 ª2012 Elsevier Ltd All rights reserved 215
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Figure 1. Microfibril Structure and Interactions
(A) Fibrillin microfibrils are found either associated with
elastin in tissues such as the skin, arteries and lung, where
they provide a scaffold for elastogenesis, or in elastin-free
bundles in tissues such as the ciliary zonule, where they
provide tensile strength.
(B) When viewed by rotary-shadowing electron micros-
copy, isolated microfibrils appear as 10 to 12 nm diam-
eter beaded filaments with an average periodicity of
50–60 nm.
(C) Although their molecular organization is still unclear,
microfibrils are known to be binding sites for several
extracellular matrix proteins (Hubmacher and Apte, 2011),
such as fibulins, microfibril-associated glycoproteins
[MAGPs (red circles)], and members of the ADAMTS
family, and function as sequestration sites for growth
factors such as TGFb and BMPs in connective tissues.
Inactive TGFb, bound to its LAP, binds to microfibrils
through the LTBPs. The interaction involves disulphide-
bond formation between the LAP and the second TB
domain (red ovals on LTBP) of LTBPs 1, 3, and 4 (Sahar-
inen and Keski-Oja, 2000). MAGP-1 binds to the
N-terminus of fibrillin-1 (Jensen et al., 2001) and has been
localized to the beaded structures of the microfibrils
(Henderson et al., 1996). The precise binding sites of the
other molecules on the microfibril are unclear and there-
fore only represented schematically in this figure.
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hybrid (hyb) domains with sequence and structural similarities
to both the cbEGF and TB domains (Corson et al., 1993; Jensen
et al., 2009; Pereira et al., 1993). The region encompassing
domains TB3 and cbEGF18 of fibrillin-1 is often referred to as
the ‘‘neonatal’’ region, because it is this part of the molecule
that is affectedbymutations that lead to themost severe neonatal
form of Marfan syndrome. The TB and hybrid domains are found
only in the fibrillins and structurally related LTBPs (Robertson
et al., 2010). Other domains include a four-cysteine N-terminal
domain, a variable domain rich in proline (fibrillin-1), glycine
(fibrillin-2), or proline and glycine (fibrillin-3), and a C terminus
that contains a highly conserved CXXC motif with a propeptide
that undergoes furin-mediated processing either during or just
after secretion (Lo¨nnqvist et al., 1998; Milewicz et al., 1992;
Raghunath et al., 1999; Ritty et al., 1999; Wallis et al., 2003). A
recent review of fibrillin sequences in vertebrates and inverte-
brates has shown that their domain organization has remained
remarkably unchanged through evolution (Robertson et al.,
2010). The importance of this conservation of domain organiza-
tion has been highlighted by the detection of exon-skipping
mutations that cause the deletion of entire human fibrillin-1
domains and tend to result in a severe Marfan syndrome216 Structure 20, February 8, 2012 ª2012 Elsevier Ltd All rights reservedphenotype (Liu et al., 1996). These observations
would suggest that the spacing of the domains
relative to each other may be functionally
significant during the assembly of microfibrils.
Recent observations on the effects of deleting
the first hybrid domain have suggested that
register is not always important in microfibril
assembly (Charbonneau et al., 2010). However
the first hybrid domain is found N-terminal
to the proline-rich domain, which is likely to
be unstructured (Ashworth et al., 1999), and
the effects of deletions affecting domainsC-terminal to the proline-rich domain, which are regularly
structured with extensive interdomain contacts and comprise
the majority of the molecule, have not been investigated. It is
also possible that fibrillin-2 could play a compensatory role in
the assembly of fibrillin-1 molecules lacking the first hybrid
domain.
TB and Hybrid Domains
With the exception of the C-terminal propeptide and
proline/glycine-rich regions, the structure of fibrillin is highly di-
sulphide-rich. Each of the TB domains contains eight cysteines,
which form four disulphide bonds in a 1-3, 2-6, 4-7, 5-8 arrange-
ment, and an N-terminal globular region stabilized by a
conserved aromatic residue (Lee et al., 2004; Yuan et al., 1997)
(Figure 2). Unlike the third eight-Cys (TB2) domains of LTBP-1,
-3, and -4, which have been shown to be involved in covalently
binding the propeptide of TGFb (the latency-associated peptide
[LAP]) through a disulphide exchange mechanism (Gleizes et al.,
1996; Saharinen and Keski-Oja, 2000; Saharinen et al., 1996),
none of the fibrillin TB domains has been observed to undergo
disulphide rearrangements. The structural basis of the LAP-
LTBP interaction has been well characterized and involves a
two-amino-acid insertion between Cys-6 and Cys-7 of the
domain (Saharinen and Keski-Oja, 2000), leading to increased
Figure 2. Structures and Organization of Fibrillin-1 Domains
The domain organization of fibrillin-1 is dominated by cbEGF domains interspersed with TB and hyb domains. Domains TB3 to cbEGF18 form the ‘‘neonatal’’
region, in which substitutions leading to the severe neonatal form of Marfan syndrome cluster. Structures have been determined for fragments cbEFG9-hyb2-
cbEGF10 (PDB 2W86), cbEGF12-cbEGF13 (PDB 1LMJ), cbEGF22-TB4-cbEGF23 (PDB 1UZJ), isolated domain TB6 (PDB 1APJ), and cbEGF32-cbEGF33 (PDB
1EMN). Pairwise interactions of the domains in these structures suggest a near-linear organization, stabilized by calcium ions (shown in red).
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(Lack et al., 2003). This feature is absent in the fibrillin TB
domains, so it is highly unlikely that any intermolecular disulphide
bond formation would occur through this mechanism.
A recent study of a triple-domain fragment of fibrillin-1,
cbEGF9-hyb2-cbEGF10, has shown that hybrid domains have
a structure resembling the TB domains, with eight cysteine resi-
dues disulphide-bonded in a 1-3, 2-5, 4-6, 7-8 arrangement
(Jensen et al., 2009) (Figure 2). The C-terminal part of a hybrid
domain, however, resembles the C-terminal region of a cbEGF
domain, consistent with earlier predictions based on sequence
data alone and the suggestion that the hybrid domains may
have evolved from a fusion of TB and cbEGF domains (Corson
et al., 1993; Pereira et al., 1993). As in the case of the fibrillin
TB domains, none of the features associated with the disulphide
exchange mechanism seen in the LTBPs are found in the hybrid
domains. The first hybrid domain of the fibrillins is unusual,
however, in that it contains a highly conserved ninth cysteine
that may be involved in the formation of intermolecular disul-
phide bridges in the microfibrils (Reinhardt et al., 2000).
EGF and cbEGF Domains
EGF and cbEGF domains occur in a wide range of extracellular
matrix and cell-surface proteins, including proteins associated
with elastic fibers (fibulins, LTBPs) as well as proteins with unre-
lated functions, such as the Notch receptor, thrombomodulin,
the LDL receptor, and various coagulation factors (Rees et al.,
1988). cbEGF domains make up the bulk of fibrillin. These
domains are characterized by three disulphide bonds in a 1-3,
2-4, 5-6 arrangement, and the calcium-binding consensus
sequence D/N-X-D/N-E/Q-Xm-D/N*-Xn-Y/F, where m and n are
variable and * indicates possible posttranslational b-hydroxyl-Structuation (Figure 2). Calcium is bound with a pentagonal bipyramidal
geometry, with ligands provided by both side-chain oxygen
atoms and backbone carbonyl groups (Rao et al., 1995). In
some cases, such as in fibrillin-1 domain cbEGF23, all seven of
the ligands required for calcium ligation are contributed by the
protein (Lee et al., 2004). In other cases, such as in fibrillin-1
domain cbEGF10 and in domains EGF11-13 of human Notch-1,
one or two of the ligands are donated bywater molecules (Cordle
et al., 2008; Jensen et al., 2009).
Calcium Binding Stabilizes Interdomain Packing
Calcium binding by fibrillin cbEGFdomains plays a structural role
by restricting the mobility of interdomain regions (Smallridge
et al., 2003) and protecting the molecule from proteolysis (Rein-
hardt et al., 1997). It also plays a role in intermolecular inter-
actions of fibrillin by stabilizing a conformation required for
recognition by other matrix components, including heparin
(Cain et al., 2005; Tiedemann et al., 2001), MAGP-1 (Jensen
et al., 2001; Rock et al., 2004), fibulins-2, -4, and -5 (El-Hallous
et al., 2007; Reinhardt et al., 1996b), and aggrecan and versican
(Isogai et al., 2002). Calcium is also required for homotypic and
heterotypic interactions between fibrillin-1 and fibrillin-2 (Lin
et al., 2002; Marson et al., 2005).
Calcium affinities of the cbEGF domains vary across the
molecule and depend on domain context (Jensen et al., 2005;
McGettrick et al., 2000). N-terminal linkage to another domain
increases the calcium affinity of a cbEGF domain through the
stabilization of the calcium-binding pocket by hydrophobic
interdomain interactions (Smallridge et al., 1999). Kd values for
calcium binding have been measured as low as 0.3 mM in
fibrillin-1 cbEGF domains in the context of a cbEGF-cbEGF
pair (Suk et al., 2004). The attachment of an N-terminal domainre 20, February 8, 2012 ª2012 Elsevier Ltd All rights reserved 217
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Figure 3. Calcium Binding to Fibrillin-1 and Its Role in Interdomain Interactions
(A and B) Interdomain interactions in cbEGF-cbEGF pairs, such as cbEGF12-13 (A) and cbEGF32-33 (B), are stabilized by packing of conserved aromatic
residues in the N-terminal domain (Y1101 in cbEGF12 and Y2157 in cbEGF32) with an ‘‘XG’’ motif between the third and fourth cysteine residues of the C-terminal
domain (E1133-G1134 in cbEGF13 and I2185-G2186 in cbEGF33). The cbEGF12-13 interaction is further stabilized by the packing of methylene groups from
residue R1083 against the aromatic ring of Y1101.
(C and D) Heterologous domain interfaces such as in TB4-cbEGF23 (C) and hyb2-cbEGF10 (D) are stabilized by extensive interdomain hydrophobic contacts
involving the ‘‘L1’’ and ‘‘GX’’ sites, which form contacts with residues between Cys1-Cys2 (‘‘loop 1’’) and Cys3-Cys4 of the adjacent cbEGF, respectively.
(E) These interaction sites in hyb and TB domains (highlighted in the alignments in magenta and blue, respectively) are conserved in several species, especially in
domains that have been found to be involved in forming domain interactions with adjacent cbEGFs that result in high calcium affinities, suggesting a conservation
of local structure at these sites. The lack of a conserved ‘‘GX’’ motif in domain TB1 reflects the fact that this domain is followed by the Pro-rich domain rather than
by a cbEGF domain. Numbers under sequences refer to Kd values measured for calcium binding to hyb-cbEGF and TB-cbEGF pairs from human fibrillin-1
(Jensen et al., 2005, 2009). Species listed areHomo sapiens,Musmusculus, Gallus gallus (fibrillin-2), Xenopus tropicalis, Danio rerio (fibrillin-2),Ciona intestinalis,
Strongylocentrotus purpuratus, Tribolium castaneum, Acyrthosiphon pisum, Pediculus humanus, Daphnia pulex, Lottia gigantea, and Nematostella vectensis.
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Reviewis thought to facilitate the formation of a correctly presented
calcium-binding site, and the binding of calcium rigidifies the
domain interface (Werner et al., 2000). The primary sites of
cbEGF-cbEGF interdomain interactions involve a conserved
aromatic residue positioned four residues C-terminal from
Cys-5 of the N-terminal cbEGF, and an ‘‘XG’’ motif involving
a conserved glycine between Cys-3 and Cys-4 of the C-terminal
cbEGF (Figures 3A and 3B).
TB-cbEGF domain pairs show a wide range of calcium Kd
values, from 16 ± 1 nM in the case of the TB4-cbEGF23 domain
pair to 1.6 mM in the case of the TB6-cbEGF32 domain pair.
The very high calcium affinity observed for the TB4-cbEGF23
pair is the result of an extensive hydrophobic interface between
the domains, involving two separate hydrophobic packing sites
on each of the domains (Jensen et al., 2005; Lee et al., 2004).
The first of these (L1) involves hydrophobic residues between
Cys-2 and Cys-3 of the TB domain packing with residues
between Cys-1 and Cys-2 (‘‘loop 1’’) of the cbEGF domain.218 Structure 20, February 8, 2012 ª2012 Elsevier Ltd All rights reseThe second site resembles a cbEGF-cbEGF interaction, with
the turn between Cys-3 and Cys-4 of the cbEGF domains
packing against a Gly-X motif (where X is often aromatic) found
after Cys-8 of the TB domain (Figure 3C). Although the length
of the linker region between the TB and cbEGF domains was
originally thought to determine the degree of flexibility between
these domains, based on the structure of the isolated fibrillin-1
TB6 domain (Yuan et al., 1997), it has since been shown
that the hydrophobic interactions between domains have a far
greater influence on interdomain interactions (Jensen et al.,
2005). Similar hydrophobic interactions have been observed in
domain pairs involving the structurally related hybrid domains
(Figure 3D), where Kd values for calcium binding by the hyb1-
cbEGF1 and hyb2-cbEGF10 domain pairs were measured to
be 14.7 ± 3.7 nM and 8.7 ± 3.5 nM, respectively (Jensen et al.,
2009).
The wide range of calcium affinities along themolecule has the
potential to provide variations in the rigidity of domain interfacesrved
Structure
Reviewand therefore have an effect on the biomechanical properties of
the molecule. TB and hyb domains involved in forming high-
calcium-affinity domain pairs with adjacent cbEGF domains in
human fibrillin-1, such as domains hyb1, hyb2, and TB4, show
a high degree of sequence conservation at sites involved in inter-
domain packing. This sequence conservation may reflect a
conservation of the biomechanical properties at these sites
(Figure 3E), although the significance of the very high calcium
affinities at some of these sites, with Kd values several
orders of magnitude lower than the free calcium concentration
(1.0–1.2 mM) in the extracellular matrix, is unknown.
Interdomain Packing Interactions Influence
Protein-Protein Interactions
Interdomain interactions in fibrillin have a significant influence
on the molecule’s interactions with other cell surface and matrix
components. Domain TB4 of fibrillin-1 contains an RGD motif
that has been shown to be required for binding to integrins
avb3, avb6, and a5b1 (Bax et al., 2003; Jovanovic et al., 2007;
Lee et al., 2004; Pfaff et al., 1996; Sakamoto et al., 1996). The
presence of domains N-terminal to domain TB4 significantly
increases cell attachment to fibrillin fragments through avb3,
and the cbEGF22-TB4 interdomain boundary has an extensive
hydrophobic interface (Lee et al., 2004). The region around the
hyb1 domain of fibrillin-1, in particular, the EGF3-hyb1 domain
interface, is an important site of interaction with proteins such
as the fibulins and LTBPs (El-Hallous et al., 2007; Isogai et al.,
2003; Ono et al., 2009). Interactions of the hyb1 region with
fibulin-4 and -5 depend on the context of the domain (El-Hallous
et al., 2007), suggesting that interdomain interactions produce
an interaction surface spanning two or more domains. Given
that cbEGF domains form extensive contacts with adjacent TB
and hyb domains, and that calcium binding alters the dynamics
of cbEGF domain pairs (Downing et al., 1996; Jensen et al., 2005,
2009; Lee et al., 2004; Smallridge et al., 2003), these results
suggest that any intra- or intermolecular interactions of fibrillin
domains need to be considered in the native context of their
adjacent domains.
Microfibril Organization and Elasticity
Microfibril elasticity depends both on the structural integrity of
fibrillin and its ability to bind calcium, and on the organization
of individual fibrillin monomers within the microfibril (Eriksen
et al., 2001; Thurmond and Trotter, 1996). Disulphide bond
formation has a significant influence on microfibril elasticity.
The reduction of extracted microfibrils greatly increases the
compliance (Thurmond and Trotter, 1996), although at present
it is not possible to separate the relative contributions of intra-
versus intermolecular disulphides. Models of microfibril as-
sembly and organization need to provide a mechanism for their
elasticity. At the heart of the problem of understandingmicrofibril
organization is the question of how a molecule that is roughly
150 nm in length when fully extended (Lin et al., 2002; Sakai
et al., 1991) is packaged into fibrils with an average, but variable,
bead-to-bead periodicity of 55 nm (Keene et al., 1991; Kielty and
Shuttleworth, 1995).
At present, two broad categories of microfibril organization
have been proposed: a pleated model, in which fibrillin mono-
mers are folded so that each monomer fits within one interbead
repeat (Baldock et al., 2006; Glab and Wess, 2008; Lu et al.,Structu2005; Wang et al., 2009), and models in which fibrillin monomers
are extended and span two or more interbead distances (Down-
ing et al., 1996; Kuo et al., 2007; Lee et al., 2004) (Figure 4). In all
current models, fibrillin monomers are aligned in a head-to-tail
configuration with up to eight monomers per repeat, and interac-
tions between the N- and C-termini are generally thought to be
one of the earliest stages of microfibril assembly (Hubmacher
et al., 2008; Lin et al., 2002; Marson et al., 2005; Trask et al.,
1999) with these regions being localized in or near the beads of
the beaded filaments (Reinhardt et al., 1996a). The mechanism
of elasticity is still controversial, however, with little agreement
on the degree to which large-scale molecular rearrangements
(pleated models) contribute to microfibril extensibility compared
to more localized unfolding and refolding events at domain
boundaries (extended models).
Pleated Models of Microfibril Organization
An unstaggered model of fibrillin organization within microfibrils
was originally developed based on the mapping of antibody
binding sites on microfibrils imaged by electron microscopy
(Reinhardt et al., 1996a). Using data from scanning transmission
electron microscopy mass mapping, antibody mapping, and
automated electron tomography, a pleated model of microfibril
organization was developed in which each fibrillin monomer is
folded, or ‘‘pleated,’’ so that it fits within one bead-to-bead
interval (Baldock et al., 2001). In the current version of thismodel,
the N- and C-termini of fibrillin overlap, and the region between
domains TB4 and TB6 is highly compacted (Figure 4A). The
more globular TB and hybrid domains are predicted to corre-
spond with the globular features of the microfibril observed by
electron microscopy. Regions of fibrillin that have been shown
to interact with cells via integrins or heparan sulfate (Bax et al.,
2003; Cain et al., 2005; Pfaff et al., 1996; Ritty et al., 2003; Saka-
moto et al., 1996; Tiedemann et al., 2001) are predicted to cluster
in the most compact part of the model. Of the current models of
microfibril organization, this model has been shown to provide
the best fit to experimentally derived stain exclusion patterns
observed by electron microscopy of microfibrils extracted from
tissues (Lu et al., 2005).
In the pleated model, microfibril extensibility is based on
domain-domain conformational rearrangements that would
allow the molecule to become more linear under an imposed
force. This mechanism is supported by an X-ray diffrac-
tion study of microfibrils from zonular filaments in which
computer-generated patterns were used to fit X-ray data (Glab
and Wess, 2008). The application of an external strain in this
study was shown to cause a reduction in fibril diameter and
lateral spacing and an increase in axial periodicity to a maximum
of 160 nm. Although this is consistent with the unfolding of fibrillin
monomers, the extreme extension (270%) required to achieve
this periodicity is unlikely to occur physiologically, and it may
have resulted in a loss of tissue integrity, as seen in a similar
study (Haston et al., 2003).
Although the pleated model explains many of the large-scale
features of microfibrils, there are aspects of the model that
require further investigation. It provides an explanation for micro-
fibril extension through the gradual unfolding of fibrillin mono-
mers, however the mechanism of structural restoration after
the release of a stretching force is unclear. Folding of fibrillin
monomers into a low-energy state that could drive recoil wouldre 20, February 8, 2012 ª2012 Elsevier Ltd All rights reserved 219
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Figure 4. Models of Microfibril Organization
Models of microfibril organization can be broadly
categorized into two groups: those with one folded
fibrillin monomer per interbead distance (A) and
those with extended monomers extending over
two or more interbead distances (B and C). Bea-
ded structures of themicrofibril are represented by
the dashed ovals. All models propose about eight
fibrillin molecules per cross-section (not shown in
A or B).
(A) The pleated model involves folding back of the
monomer, especially in the region around domains
TB4 and TB5, and is based on data derived from
techniques such as SAXS, scanning transmission
electron microscopy mass mapping, antibody
mapping, and automated electron tomography.
Figure adapted from Baldock et al. (2006),
showing only those domains with defined posi-
tions in the model.
(B) The extended model of Kuo et al. (2007) is
based on observations made by electron micros-
copy, the identification of collagenase cleavage
sites, and antibody mapping data, and it suggests
that each fibrillin monomer spans two interbead
distances, with overlaps occurring at the beads
and involving the N- and C-termini and the
‘‘neonatal’’ region between domains TB3 and TB4.
(C) The extended model of Lee et al. (2004) is
based on high-resolution crystallographic and
NMR structural data. This is the most extended
model, with each monomer spanning three
interbead distances and at least part of the mass
of the bead made up by molecules such as
MAGP-1 (blue diamonds). The positions of trans-
glutaminase cross-links, as determined by Qian
and Glanville (1997), are shown as crosses.
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regions of the molecule or long-range structural features of the
molecule that are yet to be determined at high resolution. Small
angle X-ray scattering (SAXS) data obtained from multiple-
domain fibrillin-1 fragments suggested a nonlinear structure for
some contiguous cbEGF arrays (Baldock et al., 2006) that is in
opposition to all NMR and X-ray crystallographic studies of
fibrillin-1 fragments to date. Although the fragments studied by
these high resolution methods have been relatively small, span-
ning no more than three domains, the binding of calcium to
cbEGF domains in cbEGF-cbEGF, TB-cbEGF, and hyb-cbEGF
domain pairs has clearly been shown to stabilize conserved
hydrophobic interdomain interfaces (Downing et al., 1996; Jen-
sen et al., 2005, 2009; Lee et al., 2004; Smallridge et al., 1999).
High-resolution structural studies of longer and posttranslation-
ally modified fragments are therefore required to reconcile the
differences between the pleated model and current NMR and
X-ray crystallographic data.
Linear, Staggered Models of Microfibril Organization
Linear models of fibrillin organization within the microfibril
present fibrillin monomers in an elongated arrangement that
spans two (Downing et al., 1996; Kuo et al., 2007; Liu et al.,
1996) or three (Lee et al., 2004) interbead distances (Figures 4B
and 4C). These models are largely based on NMR and X-ray220 Structure 20, February 8, 2012 ª2012 Elsevier Ltd All rights reservedstructures of cbEGF-containing fibrillin-1
fragments (Downing et al., 1996; Lee
et al., 2004; Smallridge et al., 2003;
Yuan et al., 2002), and on the mappingof antibody binding and protease cleavage sites within fibrillin
and the microfibrils (Kuo et al., 2007). In the most recent model
by Kuo et al., the fibrillin N- and C-termini are located within
the beaded structure of the microfibril. Monomers in this model
are staggered so that the ‘‘neonatal’’ region of fibrillin (Figure 2)
is also positioned near the bead. The importance of this part of
fibrillin-1 is suggested by the especially severeMarfan syndrome
phenotypes resulting from mutations affecting these domains,
although the precise role of this region in microfibril assembly
has not been clearly determined. The model also suggests an
asymmetric positioning of the N- and C-termini, with the
N-terminal half of the molecule overlaying a core formed by the
C-terminal half (Kuo et al., 2007).
This model fits the current antibody mapping data and is
based on more refined sequence specificities of the epitopes
determined in an earlier study (Reinhardt et al., 1996a). The
extended conformation of the fibrillin-1 monomers is supported
by current atomic-resolution structures (Downing et al., 1996;
Jensen et al., 2009; Lee et al., 2004; Smallridge et al., 2003)
and observations of recombinant full-length fibrillin-1 monomers
by electron microscopy (Lin et al., 2002). The positioning of the
N- and C-terminal halves relative to each other is also consistent
with the observations of Hubmacher et al., who showed that the
C-terminal half of fibrillin-1 was able to assemble into structures
AB
Figure 5. Mechanism of Microfibril Extensibility
(A) The crystal structure of the cbEGF22-TB4-cbEGF23
integrin-binding fragment of fibrillin-1 (Lee et al., 2004)
showed that the linker region between TB (blue) and
cbEGF (green) domains could function as a molecular
spring through their interactions with calcium (red).
(B) The high Ca2+ affinities observed at some TB-cbEGF
domain interfaces (Jensen et al., 2005) suggests a mech-
anism for recoil after extension at these sites, while
maintaining the overall fold of the individual domains and
allowing for interactions with other proteins (orange).
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Reviewthat resembled the beads of the beaded filament (Hubmacher
et al., 2008).
Elongated models of microfibril organization propose that
fibrillin monomers are staggered within the microfibril, so that
the N- and C-terminal domains overlap with central regions of
neighboring molecules (Figures 4B and 4C). Based on the
observation that fibrillin monomers have a length of 150 nm
(Lin et al., 2002; Sakai et al., 1991), elongated models of fibrillin
organization would therefore suggest that reversible extensi-
bility of the microfibrils is limited to interbead periodicities
of <100 nm without a significant change in intermolecular
contacts or damage to the bead structure. In their model, Kuo
et al. suggest that observations of periodicities of up to
160 nm seen in studies using microfibrils isolated by collage-
nase treatment are due to cross-linked monomers being held
together after cleavage of fibrillin at sites near the N-terminus
(Kuo et al., 2007). Structural data for fibrillin-1 fragments
provides an explanation for the extensibility of microfibrilsStructure 20, February 8based on interdomain interactions. Lee et al.
proposed a mechanism in which the interdo-
main linker regions between TB and cbEGF
domains act like a molecular spring that unfolds
in response to application of a stretching force
(Figure 5A) (Lee et al., 2004). The high calcium
affinities of most fibrillin TB-cbEGF (Jensen
et al., 2005) and hyb-cbEGF (Jensen et al.,
2009) domain interfaces suggest an obvious
recoil mechanism. Under physiological condi-
tions, these domain interfaces would be in a
fully calcium-bound form. Under extension,
unfolding of the domain interface would occur,
resulting in a reduction of calcium affinity and
loss of the bound calcium ion. A return to the
relaxed state would then be driven by the
calcium-dependent stabilization and refolding
of domain interfaces (Figure 5B). It has been
estimated that TB-cbEGF interfaces could
contribute up to 5 nm each on extension, or
about 30 nm from all six TB-cbEGF pairs (Lee
et al., 2004), while hyb-cbEGF interfaces may
contribute an extra 3.5 nm each (Jensen
et al., 2009). The potential contributions of the
proline-rich domain and tandem cbEGF repeats
to microfibril extensibility are unknown. cbEGF
repeats are unlikely to play a large role in exten-
sibility, since microfibril periodicity has been
shown to be at maximum under conditions inwhich cbEGF repeats are calcium-saturated and fully extended
(Cardy and Handford, 1998).
The Role of Fibrillin Structure in Disease Pathogenesis
Disease-associatedmutations occur throughout the FBN1 gene.
Disruption of the quantity or functional capacity of microfibrils as
a result of thesemutations leads to the perturbed TGFb signaling
seen in fibrillinopathies (Le Goff et al., 2011; Loeys et al., 2010;
Ramirez et al., 2008; Ramirez and Dietz, 2007; Ramirez and
Rifkin, 2009), with the majority of mutations causing loss-of-
function phenotypes affecting the eyes and the cardiovascular
and skeletal systems, as seen in Marfan syndrome. Excluding
mutations that result in nonsense-mediated decay of RNA and
a reduction in the total amount of fibrillin-1 produced, the effects
of fibrillin-1 mutations on protein structure can be described by
two broad classes: (1) truncated molecules resulting from muta-
tions such as nonsense codons positioned in the last exon and
splicing errors, and (2) missense mutations that result in the
production of full-length fibrillin-1 monomers with single-residue, 2012 ª2012 Elsevier Ltd All rights reserved 221
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many of the substitutions involved in Marfan syndrome affect
structurally important residues such as the cysteine residues of
TB and cbEGF domains, and these substitutions by definition
result in domain misfolding and in some cases lead to intracel-
lular retention (Whiteman and Handford, 2003; Whiteman et al.,
2007). Others affect residues involved in the binding of calcium
by cbEGF domains, causing a reduction in the calcium affinity
of the domain and altering the interactions of tandem cbEGF
domains and therefore the rigidity of the molecule (Cardy and
Handford, 1998; Smallridge et al., 1999).
Very recently, a series of missense mutations localized to
domains TB4 and TB5 were identified as having specific geno-
type-phenotype correlations. Although mutations that cause
Marfan syndrome have been found in both these domains, muta-
tions associated with stiff skin syndrome (SSS) have only been
found in domain TB4 (Loeys et al., 2010), and the majority of
known disease-causing missense mutations found in TB5 are
associated with acromicric dysplasia and geleophysic dysplasia
(Le Goff et al., 2011). Interestingly, all of these newly described
fibrillinopathies have features, including short stature, skin thick-
ening, and joint stiffness, that are markedly different from those
seen in Marfan syndrome. Domains TB4 and TB5 both form
TB-cbEGF pairs with adjacent domains that display very high
calcium affinities (TB4-cbEGF23 Kd = 16 nM; TB5-cbEGF25
Kd = 136 nM) (Jensen et al., 2005), so the substitutions in these
TB domains may affect interdomain packing, calcium binding,
and the rigidity of these parts of the polypeptide. It has also
been shown that SSS substitutions can impair integrin binding
and signaling (Loeys et al., 2010), possibly by altering the confor-
mation of the Arg-Gly-Asp loop of domain TB4. At present, the
degree of structural disruption caused by the known SSS substi-
tutions, all of which alter the number of cysteine residues in
domain TB4, remains unknown.
In the case of the geleophysic and acromicric dysplasias,
several of the disease-causing substitutions are expected to
cause protein misfolding either through the removal or introduc-
tion of cysteine residues (Le Goff et al., 2011). In other cases, the
substitutions require further high-resolution structural investiga-
tions to determine their mechanism of action. The region around
domain TB5 has been implicated in heparin binding, and it has
been suggested that fibrillin-1 binding to heparan sulfate proteo-
glycans is an important step in microfibril assembly (Tiedemann
et al., 2001), so it could be speculated that these substitutions
disrupt a molecular surface on fibrillin-1 that is involved in an
intermolecular interaction. Domain TB5 is also the site of a dele-
tion that results in Weill-Marchesani syndrome (Faivre et al.,
2003), another fibrillinopathy that results in short stature, brachy-
dactyly, and ocular defects. Weill-Marchesani and geleophysic
dysplasia are also causedbymutations in thegenesencoding the
protease ADAMTS10 and the structurally related ADAMTSL2,
respectively, which in recent years have been shown to interact
with fibrillin-1 (Kutz et al., 2011; Le Goff et al., 2011). It is still to be
determined how the structural defects in domain TB5 result in
a disease phenotype that is so different from the Marfan syn-
drome phenotype seen with the majority of fibrillin-1 mutations,
how these relate to the functions of ADAMTS10 and ADAMTSL2
in the microfibrils, and what these newly described syndromes
can tell us about microfibril assembly and function.222 Structure 20, February 8, 2012 ª2012 Elsevier Ltd All rights reseConclusions
Recent structural studies of fibrillin-1 domains and their interac-
tions have provided new insights into the molecular organization
and interactions of the 10 to 12 nm diameter extracellular matrix
microfibrils. The highly disulphide-bonded nature of these
structures provides them with the resilience required in force-
bearing tissues, while calcium binding to cbEGF domains rigid-
ifies the microfibrils and contributes to their protection from
degradation by proteases. Based on high-resolution structural
information, a mechanism for microfibril extensibility is pro-
posed, with TB-cbEGF domain interfaces providing regions of
extension coupled to a recoil mechanism driven by high calcium
affinity, which does not disrupt the extensive cell-matrix interac-
tions. These studies have also provided information on the
pathogenesis of microfibril-associated diseases and will be
more important in the future for understanding the molecular
basis of diseases such as Marfan syndrome and the acromicric
and geleophysic dysplasias, which are all caused bymutations in
the fibrillin-1 gene but result in vastly different phenotypes.
Although most of the structure of fibrillin-1 is now understood
at the domain level, further work is required to understand the
structure of the highly interactive N- and C-terminal regions of
fibrillin-1 and the protein-protein interactions involved in microfi-
bril assembly and matrix regulation.
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